SEC Form 4 · accession 0001193125-26-264040
Axsome Therapeutics, Inc. · AXSM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Susan Mahony
Director
Period of report
Jun 5, 2026
Accepted (ET)
Jun 9, 2026 · 5:18 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001579428
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF1,F2 | — | Jun 5, 2026 | A | 1,721 | A | — | — | Common Stock | 1,721 | 1,721 | D |
Explanation of responses
- F1Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock.
- F2The RSUs vest in full on the one-year anniversary of the date of grant.